These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34577590)

  • 21. Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction.
    Chiang MC; Cheng YC; Chen SJ; Yen CH; Huang RN
    Exp Cell Res; 2016 Oct; 347(2):322-31. PubMed ID: 27554603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer's Disease and Depression.
    El Massry M; Alaeddine LM; Ali L; Saad C; Eid AA
    Curr Med Chem; 2021; 28(12):2328-2345. PubMed ID: 32900343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of metformin on recognition memory and hippocampal neuroplasticity in rats with metabolic syndrome.
    Muñoz-Arenas G; Pulido G; Treviño S; Vázquez-Roque R; Flores G; Moran C; Handal-Silva A; Guevara J; Venegas B; Díaz A
    Synapse; 2020 Sep; 74(9):e22153. PubMed ID: 32190918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
    Ettcheto M; Sánchez-López E; Gómez-Mínguez Y; Cabrera H; Busquets O; Beas-Zarate C; García ML; Carro E; Casadesus G; Auladell C; Vázquez Carrera M; Folch J; Camins A
    Mol Neurobiol; 2018 Sep; 55(9):7327-7339. PubMed ID: 29404958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease.
    Haan MN
    Nat Clin Pract Neurol; 2006 Mar; 2(3):159-66. PubMed ID: 16932542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugs.
    Balbaa M; Abdulmalek SA; Khalil S
    PLoS One; 2017; 12(5):e0172429. PubMed ID: 28505155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liraglutide Protects Against Brain Amyloid-β
    Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
    Batista AF; Forny-Germano L; Clarke JR; Lyra E Silva NM; Brito-Moreira J; Boehnke SE; Winterborn A; Coe BC; Lablans A; Vital JF; Marques SA; Martinez AM; Gralle M; Holscher C; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
    J Pathol; 2018 May; 245(1):85-100. PubMed ID: 29435980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic literature review of the effect of insulin sensitizers on the cognitive symptoms of Alzheimer's Disease in transgenic mice.
    Craig A; Parvez F; Issberner J
    Behav Brain Res; 2019 Oct; 372():112015. PubMed ID: 31255671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of liraglutide in Alzheimer's disease pathology.
    Vargas-Soria M; Carranza-Naval MJ; Del Marco A; Garcia-Alloza M
    Alzheimers Res Ther; 2021 Jun; 13(1):112. PubMed ID: 34118986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A metabolic perspective of late onset Alzheimer's disease.
    Ettcheto M; Cano A; Busquets O; Manzine PR; Sánchez-López E; Castro-Torres RD; Beas-Zarate C; Verdaguer E; García ML; Olloquequi J; Auladell C; Folch J; Camins A
    Pharmacol Res; 2019 Jul; 145():104255. PubMed ID: 31075308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linking insulin with Alzheimer's disease: emergence as type III diabetes.
    Ahmed S; Mahmood Z; Zahid S
    Neurol Sci; 2015 Oct; 36(10):1763-9. PubMed ID: 26248483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide association studies: is there a genotype for cognitive decline in older persons with type 2 diabetes?
    Abbatecola AM; Olivieri F; Corsonello A; Antonicelli R; Corica F; Lattanzio F
    Curr Pharm Des; 2011; 17(4):347-56. PubMed ID: 21352095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect.
    Picone P; Nuzzo D; Caruana L; Messina E; Barera A; Vasto S; Di Carlo M
    Biochim Biophys Acta; 2015 May; 1853(5):1046-59. PubMed ID: 25667085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links.
    Rojas M; Chávez-Castillo M; Bautista J; Ortega Á; Nava M; Salazar J; Díaz-Camargo E; Medina O; Rojas-Quintero J; Bermúdez V
    World J Diabetes; 2021 Jun; 12(6):745-766. PubMed ID: 34168725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease.
    Pilipenko V; Narbute K; Pupure J; Langrate IK; Muceniece R; Kluša V
    Eur J Pharmacol; 2020 Aug; 881():173290. PubMed ID: 32580040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells.
    Kornelius E; Lin CL; Chang HH; Li HH; Huang WN; Yang YS; Lu YL; Peng CH; Huang CN
    CNS Neurosci Ther; 2015 Jul; 21(7):549-57. PubMed ID: 26010513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.